Michael L. Manning
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Acute Myeloid Leukemia Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Richard Pazdur (1 shared paper)Paresma Patel (1 shared paper)Christopher M. Sheth (1 shared paper)Aviva C. Krauss (1 shared paper)Anamitro Banerjee (1 shared paper)Donna Przepiorka (1 shared paper)Stacy S. Shord (1 shared paper)Wentao Fu (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)The Journal of Immunology (2 papers)Regulatory Toxicology and Pharmacology (2 papers)The Prostate (1 paper)
- Partner nations
- United States
In The Last Decade
Michael L. Manning
7 papers receiving 332 citations
Michael L. Manning's Hit Papers
Peers
Comparison fields: 5 of 68
- Biomaterials 115
- Hematology 69
- Oncology 79
- Immunology 60
- Genetics 25
Countries citing papers authored by Michael L. Manning
This map shows the geographic impact of Michael L. Manning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Manning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Manning more than expected).
Fields of papers citing papers by Michael L. Manning
This network shows the impact of papers produced by Michael L. Manning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Manning. The network helps show where Michael L. Manning may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael L. Manning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia Hit paper breakdown → | 2018 | 252 |
| 2 | 2016 | 33 | |
| 3 | 2013 | 21 | |
| 4 | 2015 | 10 | |
| 5 | 2024 | 7 | |
| 6 | 2011 | 5 | |
| 7 | 2019 | 5 |
About Michael L. Manning
Michael L. Manning is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology, Immunology, Molecular Biology and Oncology, having authored 7 papers that have together received 333 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers), Renal Diseases and Glomerulopathies (1 paper), Prostate Cancer Treatment and Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Complement system in diseases (1 paper). The work is most often cited by research in Biomaterials (115 citations), Hematology (69 citations), Oncology (79 citations), Immunology (60 citations) and Genetics (25 citations). Michael L. Manning has collaborated with scholars based in United States. Frequent co-authors include Richard Pazdur, Paresma Patel, Christopher M. Sheth, Aviva C. Krauss, Anamitro Banerjee, Donna Przepiorka, Stacy S. Shord, Wentao Fu, Kirsten B. Goldberg and Xin Gao. Their work appears in journals such as Clinical Cancer Research, The Journal of Immunology, Regulatory Toxicology and Pharmacology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.